Synapse - Adult Leukemia

Results (3720)

Evaluation of tagraxofusp (SL-401) alone and in combination with ruxolitinib for the treatment of myeloproliferative neoplasms

Meeting Abstract

Krishnan, A.; Pagane, M.; Roshal, M.; McGovern, E.; Stone-Molloy, Z.; Chen, J.; Brooks, C.; Levine, R. L.; Rampal, R. K.
Blood (2019)

Fulltext@MSK | Save

Acute leukemia with lineage infidelity: Mixed phenotype AML exhibits a distinct immunophenotype with clinical features overlapping mixed phenotype acute leukemia

Meeting Abstract

Kresch, M. P.; Xiao, W.; Menghrajani, K.; Famulare, C.; Patel, M. A.; Baik, J.; Roshal, M.; Levine, R. L.; Tallman, M. S.; Glass, J. L.
Blood (2019)

Fulltext@MSK | Save

Choice of hypomethylating agent (HMA) for initial treatment does not influence outcome or survival for therapy-related myeloid neoplasms (t-MN)

Meeting Abstract

Kabel, C. C.; Goldman, D. A.; Buie, L. W.; Klimek, V. M.
Blood (2019)

Fulltext@MSK | Save

Hematological count recovery in patients undergoing treatment with chimeric antigen receptor T cells (CAR T)

Meeting Abstract

Jain, T.; Knezevic, A.; Pennisi, M.; Ruiz, J. D.; Devlin, S. M.; Maloy, M. A.; Halton, E.; Diamonte, C.; Scordo, M.; Sauter, C. S.; more...
Blood (2019)

Fulltext@MSK | Save

MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy

Meeting Abstract

Imber, B.; Palomba, M. L.; DeSelm, C.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; Noy, A.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
Blood (2019)

Fulltext@MSK | Save

Early experience using radiotherapy as a salvage treatment for relapsed or refractory non-Hodgkin lymphomas following CD19 chimeric antigen receptor modified T-cell therapy

Meeting Abstract

Imber, B.; Palomba, M. L.; DeSelm, C.; Dahi, P. B.; Sauter, C. S.; Scordo, M.; Batlevi, C. L.; Park, J. H.; Shah, G. L.; Giralt, S. A.; more...
Blood (2019)

Fulltext@MSK | Save

Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia patients at first relapse: A multi-center outcomes analysis

Meeting Abstract

Hu, R.; Wei, W.; Gonter-Aubin, K.; Pinilla Ibarz, J.; Kabel, C. C.; Mato, A. R.; Madanat, Y. F.; Khajavian, S.; Shadman, M.; Hanlon, A.; more...
Blood (2019)

Fulltext@MSK | Save

Management of CAR T-cell toxicities: Concordance and divergence between healthcare providers and expert consensus recommendations

Meeting Abstract

Frigault, M.; Cartwright, M.; Marcello, K.; Quill, T. A.; DeAngelo, D. J.; Galinsky, I.; Paul, S.; Park, J. H.
Blood (2019)

Fulltext@MSK | Save

Cardiovascular (CV)-related hospitalizations and associated costs among US patients in simplicity: An observational study of patients with chronic-phase chronic myeloid leukemia (CP-CML) in routine clinical practice

Meeting Abstract

Goldberg, S. L.; Mauro, M. J.; Cortes, J. E.; Keating, S. J.; Bhandari, H.; Chen, C.
Blood (2019)

Fulltext@MSK | Save

Younger patients with newly diagnosed FLT3-mutant AML treated with crenolanib plus chemotherapy achieve adequate free crenolanib levels and durable remissions

Meeting Abstract

Goldberg, A. D.; Coombs, C. C.; Wang, E. S.; Walter, R. B.; Karanes, C.; Vigil, C. E.; Messahel, B.; Stone, R. M.; Collins, R. H.
Blood (2019)

Fulltext@MSK | Save